Indications and uses
for the temporary relief of pain and itching associated with minor lip irritation or cold sores temporarily protects and helps relieve chapped or cracked lips
for the temporary relief of pain and itching associated with minor lip irritation or cold sores temporarily protects and helps relieve chapped or cracked lips
adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily children under 2 years of age: Consult a doctor
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Camphor 0.5% (w/w) | External analgesic |
| Dimethicone 1.1% (w/w) | Lip protectant |
| Menthol 0.625% (w/w) | External analgesic |
| Phenol 0.5% (w/w) | External analgesic |
For external use only
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
allantoin, ammonium hydroxide, beeswax, calcium disodium EDTA, calcium hydroxide, cetyl alcohol, flavors, glycerin, hydrated silica, lanolin, lauric acid, mineral oil, myristic acid, oleic acid, palmitic acid, paraffin, petrolatum, polyglyceryl-3 diisostearate, potassium hydroxide, purified water, SD alcohol 36, sodium hydroxide, sodium saccharin, stearyl alcohol
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2107300 | camphor 0.5 % / dimethicone 1.1 % / menthol 0.625 % / phenol 0.5 % Topical Ointment | PSN | 4 |
| 2107300 | camphor 0.005 MG/MG / dimethicone 0.011 MG/MG / menthol 0.00625 MG/MG / phenol 0.005 MG/MG Topical Ointment | SCD | 4 |
| 2107300 | camphor 0.5 % / dimethicone 1.1 % / menthol 0.625 % / phenol 0.5 % Topical Ointment | SY | 4 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9951-1 | Blistex Medicated | 6 g in 1 TUBE | OINTMENT | 6 | 4 | |
| 10157-9951-2 | Blistex Medicated | 1 in 1 CARTON | OINTMENT | 1 | 4 | |
| 10157-9951-3 | Blistex Medicated | 10 g in 1 TUBE | OINTMENT | 10 | 4 | |
| 10157-9951-4 | Blistex Medicated | 2.25 g in 1 TUBE | OINTMENT | 2.25 | 4 | |
| 10157-9951-5 | Blistex Medicated | 8 g in 1 TUBE | OINTMENT | 8 | 4 | |
| 10157-9951-6 | Blistex Medicated | 6 g in 1 TUBE | OINTMENT | 6 | 4 | |
| 10157-9951-7 | Blistex Medicated | 3 in 1 CARTON | OINTMENT | 3 | 4 | |
| 10157-9951-7 | Blistex Medicated | 6 g in 1 TUBE | OINTMENT | 6 | 4 | |
| 10157-9951-8 | Blistex Medicated | 4 in 1 CARTON | OINTMENT | 4 | 4 | |
| 10157-9951-8 | Blistex Medicated | 6 g in 1 TUBE | OINTMENT | 6 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9951 | BLISTEX MEDICATED (DIMETHICONE, CAMPHOR (SYNTHETIC), MENTHOL, AND PHENOL) OINTMENT [BLISTEX INC.] | 4 | Current NDC, Legacy NDC, 10 package rows | 20241213_e95439d3-f12b-4c1c-999a-79f2ddba4cfb.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10157-9951-2 | GM - Gram | 10157-9951 | 95deb1e4-cebc-4c0f-abdf-bea69a3668c1 | 1 | 2014-04-03 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Camphor (synthetic) | ACTIVE INGREDIENT | 5TJD82A1ET | 1 | |
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| Phenol | ACTIVE INGREDIENT | 339NCG44TV | 1 | |
| Camphor (synthetic) | ACTIVE MOIETY | 5TJD82A1ET | 1 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| Phenol | ACTIVE MOIETY | 339NCG44TV | 1 | |
| allantoin | INACTIVE INGREDIENT | 344S277G0Z | 1 | |
| ammonia | INACTIVE INGREDIENT | 5138Q19F1X | 1 | |
| calcium hydroxide | INACTIVE INGREDIENT | PF5DZW74VN | 1 | |
| cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| edetate calcium disodium anhydrous | INACTIVE INGREDIENT | 8U5D034955 | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| hydrated silica | INACTIVE INGREDIENT | Y6O7T4G8P9 | 1 | |
| lanolin | INACTIVE INGREDIENT | 7EV65EAW6H | 1 | |
| lauric acid | INACTIVE INGREDIENT | 1160N9NU9U | 1 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| myristic acid | INACTIVE INGREDIENT | 0I3V7S25AW | 1 | |
| oleic acid | INACTIVE INGREDIENT | 2UMI9U37CP | 1 | |
| palmitic acid | INACTIVE INGREDIENT | 2V16EO95H1 | 1 | |
| paraffin | INACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| polyglyceryl-3 diisostearate | INACTIVE INGREDIENT | 46P231IQV8 | 1 | |
| potassium hydroxide | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| saccharin sodium | INACTIVE INGREDIENT | SB8ZUX40TY | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| yellow wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10157-9951 | 10157-9951-1, 10157-9951-3, 10157-9951-4, 10157-9951-5, 10157-9951-6, 10157-9951-2, 10157-9951-7, 10157-9951-8 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| palmitic acid | PALMITIC ACID | 2V16EO95H1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | NA | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| ammonia | AMMONIA SOLUTION | 5138Q19F1X | LOTION / TOPICAL | ADJ PH | ||
| palmitic acid | PALMITIC ACID | 2V16EO95H1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | NA | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| ammonia | AMMONIA SOLUTION | 5138Q19F1X | LOTION / TOPICAL | ADJ PH | ||
| oleic acid | OLEIC ACID | 2UMI9U37CP | GEL, METERED / TOPICAL | 88 mg | ||
| lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| myristic acid | MYRISTIC ACID | 0I3V7S25AW | CAPSULE, EXTENDED RELEASE / ORAL | 1721 mg | ||
| myristic acid | MYRISTIC ACID | 0I3V7S25AW | AEROSOL, FOAM / VAGINAL | 2 %w/w | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| oleic acid | OLEIC ACID | 2UMI9U37CP | SOLUTION / TOPICAL | 7.4 %w/w | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| ammonia | AMMONIA SOLUTION | 5138Q19F1X | CREAM / TOPICAL | 5.72 %w/w | ||
| oleic acid | OLEIC ACID | 2UMI9U37CP | CREAM / TOPICAL | 25 %w/w | ||
| oleic acid | OLEIC ACID | 2UMI9U37CP | GEL, METERED / TOPICAL | 88 mg | ||
| paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| allantoin | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| oleic acid | OLEIC ACID | 2UMI9U37CP | SOLUTION / TOPICAL | 7.4 %w/w | ||
| allantoin | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION, SOLUTION / INTRAVASCULAR | 0.05 %w/v | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRA-ARTERIAL | 23 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| ammonia | AMMONIA SOLUTION | 5138Q19F1X | LOTION / TOPICAL | ADJ PH | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRA-ARTERIAL | 23 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | SOLUTION / TOPICAL | 14.02 %w/w | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | CREAM / TOPICAL | 0.5 %w/w | ||
| lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| lanolin | LANOLIN | 7EV65EAW6H | OINTMENT / TOPICAL | 10 %w/w | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRA-ARTERIAL | 23 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRAVENOUS | 23 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| oleic acid | OLEIC ACID | 2UMI9U37CP | GEL, METERED / TOPICAL | 88 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRAVENOUS | 23 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| paraffin | PARAFFIN | I9O0E3H2ZE | OINTMENT / TOPICAL | 2860 mg | ||
| potassium hydroxide | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRAVENOUS | 23 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| allantoin | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Blistex Medicated | DIMETHICONE, CAMPHOR (SYNTHETIC), MENTHOL, AND PHENOL | Blistex Inc. | e95439d3-f12b-4c1c-999a-79f2ddba4cfb | 2024-12-11 | Warnings | 10157-9951-1 10157-9951-8 10157-9951-6 10157-9951-3 10157-9951-5 10157-9951-7 10157-9951-4 10157-9951-2 10157-9951 10157995107 10157995104 10157995106 10157995102 10157995105 10157995108 10157995101 10157995103 36a0ff8e-6ede-4902-a8ec-a71496008247 e95439d3-f12b-4c1c-999a-79f2ddba4cfb |
Adverse event summaries are temporarily unavailable. Other product information remains available.